Home > > > > > Report Detail

Global Insulin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 14-Sep-2022
No. of pages: 101
Inquire Before Buying

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Insulin market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Insulin.

The Insulin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Insulin market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Novo Nordisk

- Eli Lilly

- Sanofi-Aventis

- Tonghua Dongbao

- Ganlee

- United Laboratory

- Jiangsu Wanbang

Product Type Insights

Global markets are presented by Insulin type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Insulin are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Insulin Segment by Type

- Animal Insulin

- Regular Human Insulin

- Insulin Analogue

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Insulin market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Insulin market.

Insulin Segment by Application

- Short Acting

- Intermediate Acting

- Long Acting

- Pre-Mix Insulin

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Insulin market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Insulin industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Insulin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Animal Insulin
1.2.3 Regular Human Insulin
1.2.4 Insulin Analogue
1.3 Market by Application
1.3.1 Global Insulin Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Market Size Estimates and Forecasts
2.1.1 Global Insulin Revenue 2017-2028
2.1.2 Global Insulin Sales 2017-2028
2.2 Insulin Market Size by Region: 2022 Versus 2028
2.3 Insulin Sales by Region (2017-2028)
2.3.1 Global Insulin Sales by Region: 2017-2022
2.3.2 Global Insulin Sales Forecast by Region (2023-2028)
2.3.3 Global Insulin Sales Market Share by Region (2017-2028)
2.4 Insulin Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Insulin Revenue by Region: 2017-2022
2.4.2 Global Insulin Revenue Forecast by Region (2023-2028)
2.4.3 Global Insulin Revenue Market Share by Region (2017-2028)
3 Global Insulin by Manufacturers
3.1 Global Top Insulin Manufacturers by Sales
3.1.1 Global Insulin Sales by Manufacturer (2017-2022)
3.1.2 Global Insulin Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Insulin Manufacturers by Revenue
3.2.1 Global Insulin Revenue by Manufacturer (2017-2022)
3.2.2 Global Insulin Revenue Share by Manufacturer (2017-2022)
3.3 Global Insulin Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Insulin Manufacturers Covered: Ranking by Revenue
3.4.2 Global Insulin Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Insulin Manufacturing Base Distribution, Product Type
3.5.1 Insulin Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Insulin Product Type
3.5.3 Date of International Manufacturers Enter into Insulin Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Novo Nordisk
4.1.1 Novo Nordisk Corporation Information
4.1.2 Novo Nordisk Description, Business Overview
4.1.3 Novo Nordisk Insulin Products Offered
4.1.4 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Novo Nordisk Insulin Sales by Product in 2021
4.1.6 Novo Nordisk Insulin Sales by Application in 2021
4.1.7 Novo Nordisk Insulin Sales by Geographic Area in 2021
4.1.8 Novo Nordisk Recent Developments
4.2 Eli Lilly
4.2.1 Eli Lilly Corporation Information
4.2.2 Eli Lilly Description, Business Overview
4.2.3 Eli Lilly Insulin Products Offered
4.2.4 Eli Lilly Insulin Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Eli Lilly Insulin Sales by Product in 2021
4.2.6 Eli Lilly Insulin Sales by Application in 2021
4.2.7 Eli Lilly Insulin Sales by Geographic Area in 2021
4.2.8 Eli Lilly Recent Developments
4.3 Sanofi-Aventis
4.3.1 Sanofi-Aventis Corporation Information
4.3.2 Sanofi-Aventis Description, Business Overview
4.3.3 Sanofi-Aventis Insulin Products Offered
4.3.4 Sanofi-Aventis Insulin Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Sanofi-Aventis Insulin Sales by Product in 2021
4.3.6 Sanofi-Aventis Insulin Sales by Application in 2021
4.3.7 Sanofi-Aventis Insulin Sales by Geographic Area in 2021
4.3.8 Sanofi-Aventis Recent Developments
4.4 Tonghua Dongbao
4.4.1 Tonghua Dongbao Corporation Information
4.4.2 Tonghua Dongbao Description, Business Overview
4.4.3 Tonghua Dongbao Insulin Products Offered
4.4.4 Tonghua Dongbao Insulin Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Tonghua Dongbao Insulin Sales by Product in 2021
4.4.6 Tonghua Dongbao Insulin Sales by Application in 2021
4.4.7 Tonghua Dongbao Insulin Sales by Geographic Area in 2021
4.4.8 Tonghua Dongbao Recent Developments
4.5 Ganlee
4.5.1 Ganlee Corporation Information
4.5.2 Ganlee Description, Business Overview
4.5.3 Ganlee Insulin Products Offered
4.5.4 Ganlee Insulin Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Ganlee Insulin Sales by Product in 2021
4.5.6 Ganlee Insulin Sales by Application in 2021
4.5.7 Ganlee Insulin Sales by Geographic Area in 2021
4.5.8 Ganlee Recent Developments
4.6 United Laboratory
4.6.1 United Laboratory Corporation Information
4.6.2 United Laboratory Description, Business Overview
4.6.3 United Laboratory Insulin Products Offered
4.6.4 United Laboratory Insulin Sales, Revenue and Gross Margin (2017-2022)
4.6.5 United Laboratory Insulin Sales by Product in 2021
4.6.6 United Laboratory Insulin Sales by Application in 2021
4.6.7 United Laboratory Insulin Sales by Geographic Area in 2021
4.6.8 United Laboratory Recent Development
4.7 Jiangsu Wanbang
4.7.1 Jiangsu Wanbang Corporation Information
4.7.2 Jiangsu Wanbang Description, Business Overview
4.7.3 Jiangsu Wanbang Insulin Products Offered
4.7.4 Jiangsu Wanbang Insulin Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Jiangsu Wanbang Insulin Sales by Product in 2021
4.7.6 Jiangsu Wanbang Insulin Sales by Application in 2021
4.7.7 Jiangsu Wanbang Insulin Sales by Geographic Area in 2021
4.7.8 Jiangsu Wanbang Recent Development
5 Breakdown Data by Type
5.1 Global Insulin Sales by Type (2017-2028)
5.1.1 Global Insulin Sales by Type (2017-2022)
5.1.2 Global Insulin Sales Forecast by Type (2023-2028)
5.1.3 Global Insulin Sales Market Share by Type (2017-2028)
5.2 Global Insulin Revenue Forecast by Type (2017-2028)
5.2.1 Global Insulin Revenue by Type (2017-2022)
5.2.2 Global Insulin Revenue Forecast by Type (2023-2028)
5.2.3 Global Insulin Revenue Market Share by Type (2017-2028)
5.3 Insulin Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Insulin Sales by Application (2017-2028)
6.1.1 Global Insulin Sales by Application (2017-2022)
6.1.2 Global Insulin Sales Forecast by Application (2023-2028)
6.1.3 Global Insulin Sales Market Share by Application (2017-2028)
6.2 Global Insulin Revenue Forecast by Application (2017-2028)
6.2.1 Global Insulin Revenue by Application (2017-2022)
6.2.2 Global Insulin Revenue Forecast by Application (2023-2028)
6.2.3 Global Insulin Revenue Market Share by Application (2017-2028)
6.3 Insulin Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Insulin Market Size YoY Growth 2017-2028
7.2 North America Insulin Market Facts & Figures by Country
7.2.1 North America Insulin Sales by Country (2017-2028)
7.2.2 North America Insulin Revenue by Country (2017-2028)
7.3 North America Insulin Sales by Type
7.4 North America Insulin Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Insulin Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Insulin Market Facts & Figures by Region
8.2.1 Asia-Pacific Insulin Sales by Region (2017-2028)
8.2.2 Asia-Pacific Insulin Revenue by Region (2017-2028)
8.3 Asia-Pacific Insulin Sales by Type
8.4 Asia-Pacific Insulin Sales by Application
9 Europe
9.1 Europe Insulin Market Size YoY Growth 2017-2028
9.2 Europe Insulin Market Facts & Figures by Country
9.2.1 Europe Insulin Sales by Country (2017-2028)
9.2.2 Europe Insulin Revenue by Country (2017-2028)
9.3 Europe Insulin Sales by Type
9.4 Europe Insulin Sales by Application
10 Latin America
10.1 Latin America Insulin Market Size YoY Growth 2017-2028
10.2 Latin America Insulin Market Facts & Figures by Country
10.2.1 Latin America Insulin Sales by Country (2017-2028)
10.2.2 Latin America Insulin Revenue by Country (2017-2028)
10.3 Latin America Insulin Sales by Type
10.4 Latin America Insulin Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Insulin Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Insulin Market Facts & Figures by Country
11.2.1 Middle East and Africa Insulin Sales by Country (2017-2028)
11.2.2 Middle East and Africa Insulin Revenue by Country (2017-2028)
11.3 Middle East and Africa Insulin Sales by Type
11.4 Middle East and Africa Insulin Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Insulin Supply Chain Analysis
12.2 Insulin Key Raw Materials and Upstream Suppliers
12.3 Insulin Clients Analysis
12.4 Insulin Sales Channel and Sales Model Analysis
12.4.1 Insulin Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Insulin Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Insulin Distributors
13 Market Dynamics
13.1 Insulin Industry Trends
13.2 Insulin Market Drivers
13.3 Insulin Market Challenges
13.4 Insulin Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Insulin Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Animal Insulin
Table 3. Major Manufacturers of Regular Human Insulin
Table 4. Major Manufacturers of Insulin Analogue
Table 5. Global Insulin Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Insulin Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 7. Global Insulin Sales by Region (2017-2022) & (K MT)
Table 8. Global Insulin Sales Forecast by Region (2023-2028) & (K MT)
Table 9. Global Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Insulin Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Global Insulin Sales by Manufacturer (2017-2022) & (K MT)
Table 12. Global Insulin Sales Share by Manufacturer (2017-2022)
Table 13. Insulin Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 14. Insulin Revenue Share by Manufacturer (2017-2022)
Table 15. Key Manufacturers Insulin Price (2017-2022) & (USD/MT)
Table 16. Ranking of Global Top Insulin Manufacturers by Revenue (US$ Million) in 2021
Table 17. Global Insulin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 18. Global Insulin by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin as of 2021)
Table 19. Insulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Insulin Product Type
Table 21. Date of International Manufacturers Enter into Insulin Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Novo Nordisk Corporation Information
Table 24. Novo Nordisk Description and Business Overview
Table 25. Novo Nordisk Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 26. Novo Nordisk Insulin Product
Table 27. Novo Nordisk Insulin Sales Proportion of Insulin by Product in 2021
Table 28. Novo Nordisk Insulin Sales Proportion of Insulin by Application in 2021
Table 29. Novo Nordisk Insulin Sales Proportion of Insulin by Geographic Area in 2021
Table 30. Novo Nordisk Recent Development
Table 31. Eli Lilly Corporation Information
Table 32. Eli Lilly Description and Business Overview
Table 33. Eli Lilly Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 34. Eli Lilly Insulin Product
Table 35. Eli Lilly Insulin Sales Proportion of Insulin by Product in 2021
Table 36. Eli Lilly Insulin Sales Proportion of Insulin by Application in 2021
Table 37. Eli Lilly Insulin Sales Proportion of Insulin by Geographic Area in 2021
Table 38. Eli Lilly Recent Development
Table 39. Sanofi-Aventis Corporation Information
Table 40. Sanofi-Aventis Description and Business Overview
Table 41. Sanofi-Aventis Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 42. Sanofi-Aventis Insulin Product
Table 43. Sanofi-Aventis Insulin Sales Proportion of Insulin by Product in 2021
Table 44. Sanofi-Aventis Insulin Sales Proportion of Insulin by Application in 2021
Table 45. Sanofi-Aventis Insulin Sales Proportion of Insulin by Geographic Area in 2021
Table 46. Sanofi-Aventis Recent Development
Table 47. Tonghua Dongbao Corporation Information
Table 48. Tonghua Dongbao Description and Business Overview
Table 49. Tonghua Dongbao Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Tonghua Dongbao Insulin Product
Table 51. Tonghua Dongbao Insulin Sales Proportion of Insulin by Product in 2021
Table 52. Tonghua Dongbao Insulin Sales Proportion of Insulin by Application in 2021
Table 53. Tonghua Dongbao Insulin Sales Proportion of Insulin by Geographic Area in 2021
Table 54. Tonghua Dongbao Recent Development
Table 55. Ganlee Corporation Information
Table 56. Ganlee Description and Business Overview
Table 57. Ganlee Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 58. Ganlee Insulin Product
Table 59. Ganlee Insulin Sales Proportion of Insulin by Product in 2021
Table 60. Ganlee Insulin Sales Proportion of Insulin by Application in 2021
Table 61. Ganlee Insulin Sales Proportion of Insulin by Geographic Area in 2021
Table 62. Ganlee Recent Development
Table 63. United Laboratory Corporation Information
Table 64. United Laboratory Description and Business Overview
Table 65. United Laboratory Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 66. United Laboratory Insulin Product
Table 67. United Laboratory Insulin Sales Proportion of Insulin by Product in 2021
Table 68. United Laboratory Insulin Sales Proportion of Insulin by Application in 2021
Table 69. United Laboratory Insulin Sales Proportion of Insulin by Geographic Area in 2021
Table 70. Jiangsu Wanbang Corporation Information
Table 71. Jiangsu Wanbang Description and Business Overview
Table 72. Jiangsu Wanbang Insulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 73. Jiangsu Wanbang Insulin Product
Table 74. Jiangsu Wanbang Insulin Sales Proportion of Insulin by Product in 2021
Table 75. Jiangsu Wanbang Insulin Sales Proportion of Insulin by Application in 2021
Table 76. Jiangsu Wanbang Insulin Sales Proportion of Insulin by Geographic Area in 2021
Table 77. Global Insulin Sales by Type (2017-2022) & (K MT)
Table 78. Global Insulin Sales Forecast by Type (2023-2028) & (K MT)
Table 79. Global Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 80. Global Insulin Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 81. Global Insulin Sales by Application (2017-2022) & (K MT)
Table 82. Global Insulin Sales Forecast by Application (2023-2028) & (K MT)
Table 83. Global Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 84. Global Insulin Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 85. North America Insulin Sales by Country (2017-2022) & (K MT)
Table 86. North America Insulin Sales by Country (2023-2028) & (K MT)
Table 87. North America Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 88. North America Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 89. North America Insulin Sales by Type (2017-2022) & (K MT)
Table 90. North America Insulin Sales by Application (2017-2022) & (K MT)
Table 91. Asia-Pacific Insulin Sales by Region (2017-2022) & (K MT)
Table 92. Asia-Pacific Insulin Sales by Region (2023-2028) & (K MT)
Table 93. Asia-Pacific Insulin Revenue by Region (2017-2028) & (US$ Million)
Table 94. Asia-Pacific Insulin Revenue by Region (2023-2028) & (US$ Million)
Table 95. Asia-Pacific Insulin Sales by Type (2017-2022) & (K MT)
Table 96. Asia-Pacific Insulin Sales by Application (2017-2022) & (K MT)
Table 97. Europe Insulin Sales by Country (2017-2022) & (K MT)
Table 98. Europe Insulin Sales by Country (2023-2028) & (K MT)
Table 99. Europe Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 100. Europe Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 101. Europe Insulin Sales by Type (2017-2022) & (K MT)
Table 102. Europe Insulin Sales by Application (2017-2022) & (K MT)
Table 103. Latin America Insulin Sales by Country (2017-2022) & (K MT)
Table 104. Latin America Insulin Sales by Country (2023-2028) & (K MT)
Table 105. Latin America Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 106. Latin America Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 107. Latin America Insulin Sales by Type (2017-2022) & (K MT)
Table 108. Latin America Insulin Sales by Application (2017-2022) & (K MT)
Table 109. Middle East and Africa Insulin Sales by Country (2017-2022) & (K MT)
Table 110. Middle East and Africa Insulin Sales by Country (2023-2028) & (K MT)
Table 111. Middle East and Africa Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 113. Middle East and Africa Insulin Sales by Type (2017-2022) & (K MT)
Table 114. Middle East and Africa Insulin Sales by Application (2017-2022) & (K MT)
Table 115. Insulin Key Raw Materials, Industry Status and Trend
Table 116. Insulin Key Raw Materials and Upstream Suppliers
Table 117. Insulin Clients Status and Trend
Table 118. Insulin Typical Clients
Table 119. Insulin Distributors
Table 120. Insulin Market Trends
Table 121. Insulin Market Drivers
Table 122. Insulin Market Challenges
Table 123. Insulin Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Product Picture
Figure 2. Global Insulin Sales Market Share by Type in 2021 & 2028
Figure 3. Animal Insulin Product Picture
Figure 4. Regular Human Insulin Product Picture
Figure 5. Insulin Analogue Product Picture
Figure 6. Global Insulin Sales Market Share by Application in 2021 & 2028
Figure 7. Short Acting Examples
Figure 8. Intermediate Acting Examples
Figure 9. Long Acting Examples
Figure 10. Pre-Mix Insulin Examples
Figure 11. Insulin Report Years Considered
Figure 12. Global Insulin Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Insulin Market Size 2017-2028 (US$ Million)
Figure 14. Global Insulin Sales 2017-2028 (K MT)
Figure 15. Global Insulin Market Size Market Share by Region: 2022 Versus 2028
Figure 16. Global Insulin Sales Market Share Forecast by Region (2017-2028)
Figure 17. Global Insulin Revenue Market Share by Region (2017-2028)
Figure 18. Global Insulin Sales Share by Manufacturer in 2021
Figure 19. Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Insulin Sales Market Share Forecast by Type (2017-2028)
Figure 21. Global Insulin Revenue Market Share Forecast by Type (2017-2028)
Figure 22. Insulin Average Selling Price (ASP) by Type (2017-2022) & (USD/MT)
Figure 23. Global Insulin Sales Market Share Forecast by Application (2017-2028)
Figure 24. Global Insulin Revenue Market Share Forecast by Application (2017-2028)
Figure 25. Insulin Average Selling Price (ASP) by Application (2017-2022) & (USD/MT)
Figure 26. North America Insulin Revenue 2017-2028 (US$ Million)
Figure 27. North America Insulin Sales Market Share by Type (2017-2022)
Figure 28. North America Insulin Sales Market Share by Application (2017-2022)
Figure 29. Asia-Pacific Insulin Revenue 2017-2028 (US$ Million)
Figure 30. Asia-Pacific Insulin Sales Market Share by Region (2017-2028)
Figure 31. Asia-Pacific Insulin Revenue Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Insulin Sales Market Share by Type (2017-2022)
Figure 33. Asia-Pacific Insulin Sales Market Share by Application (2017-2022)
Figure 34. Europe Insulin Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Europe Insulin Sales Market Share by Country (2017-2028)
Figure 36. Europe Insulin Revenue Market Share by Country (2017-2028)
Figure 37. Europe Insulin Sales Market Share by Type (2017-2022)
Figure 38. Europe Insulin Sales Market Share by Application (2017-2022)
Figure 39. Latin America Insulin Revenue Growth Rate 2017-2028 (US$ Million)
Figure 40. Latin America Insulin Sales Market Share by Country (2017-2028)
Figure 41. Latin America Insulin Revenue Market Share by Country (2017-2022)
Figure 42. Latin America Insulin Sales Market Share by Type (2017-2022)
Figure 43. Latin America Insulin Sales Market Share by Application (2017-2022)
Figure 44. Middle East and Africa Insulin Revenue Growth Rate 2017-2028 (US$ Million)
Figure 45. Middle East and Africa Insulin Sales Market Share by Country (2017-2028)
Figure 46. Middle East and Africa Insulin Revenue Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Insulin Sales Market Share by Type (2017-2022)
Figure 48. Middle East and Africa Insulin Sales Market Share by Application (2017-2022)
Figure 49. Insulin Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Insulin Raw Materials by Region in 2021
Figure 51. Insulin Distribution Channels
Figure 52. Global Insulin Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 53. Global Insulin Percentage 2017-2028: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs